The case of a woman whose von Willebrand syndrome (VWS) resolved spontaneously after being treated for rectal cancer, was reported in a recent study.
News
Platelets in active immune thrombocytopenia (ITP) have unique changes in genetic activity that make them more activated than platelets from healthy people or from…
An elderly man initially thought to have primary immune thrombocytopenia (ITP), which occurs without an identifiable underlying cause, was later found to have a…
Acquired von Willebrand syndrome (AVWS) mainly presents as two distinct clinical and laboratory profiles, depending on the underlying blood condition, according to a new study.
New classes of second-line drugs targeting the immune pathways involved in the autoimmune attacks that cause immune thrombocytopenia (ITP) significantly boost platelet counts in…
People in remission from immune-mediated thrombotic thrombocytopenic purpura (iTTP) may have a higher risk of certain major cardiovascular events, particularly stroke, according to a…
Regulatory authorities in Japan have approved Sanofi’s oral therapy Wayrilz (rilzabrutinib) for treating people with immune thrombocytopenia (ITP) who haven’t responded to,…
Dangerous blood clots that block blood flow are rare in people with von Willebrand disease (VWD), but their risk increases with age and the…
Four weekly injections of the antibody therapy daratumumab restored a key enzyme’s activity and triggered a two-year recovery for a woman with hard-to-treat immune-mediated…
A donor stem cell transplant and follow-up treatments helped a teenage girl achieve long-term remission from refractory immune thrombocytopenia (ITP), according to a case…
